Allergy Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Allergy Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Allergy Diagnostics Market is expected to witness a CAGR of 11.3% during the forecast period.

The COVID-19 pandemic has posed serious challenges to healthcare systems and has largely been controlled by drastically cutting down in- and outpatient services for diseases and implementing infection prevention and control measures. The lockdown all over the globe has affected the supply chain of diagnostic kits and other diagnostic supplies. The pandemic has significantly impacted the growth of the allergic diagnostics market due to the pandemic situation and restrictions, healthcare settings such as hospitals and diagnostic centers were temporary. For instance, according to an article published by the Clinical and Translational Allergy, in September 2021, titled ‘Recent advances and developments in COVID-19 in the context of allergic diseases, it has been observed that the United States and United Kingdom (UK) had increased prevalence of COVID-19 in patients with asthma. In addition, as per the same source, the Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI) surveyed its 14 member countries that found that the COVID-19 pandemic had an elevated prevalence of allergy illnesses, such as ocular and airway allergies with extended use of surgical masks and eye protection, skin allergy due to prolonged use of gloves, among healthcare personnel. Additionally, in an article published by the Clinical and Translational Allergy, in January 2022, titled ‘Allergic patients during the COVID-19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey’, it has been observed that the pandemic had an impact on medical professionals who treated allergic patients in terms of diagnostic, management, and treatment techniques, including allergen immunotherapy (AIT) for food, insect venom, and respiratory allergies. Moreover, most allergy/immunology care was delayed or postponed, or handled through virtual care. For patients with asthma of a certain severity, there was a limited provision for face-to-face visits under critical conditions. Such factors have impacted the market growth during the pandemic.

Certain factors that are propelling the market growth are increasing incidences of allergic diseases and environmental pollution.

The rising incidences of allergic diseases such as hives, atopic dermatitis, allergic conjunctivitis, and others are expected to increase the market growth. For instance, according to an article published by StatPearls, in August 2021, titled 'Eczema', it has been observed that the lifetime prevalence of eczema in children is between 15-30% and 2-10% in adults. In addition, as per the same source, about 50% of the patients with severe atopic dermatitis are likely to develop asthma and 75% are likely to develop allergic rhinitis. Additionally, according to an article published by Annals of Allergy, Asthma, and Immunology, in July 2021, titled ‘Rhinitis prevalence and association with atopic dermatitis, as per the meta-analysis the pooled prevalence of rhinitis was 40.5% in patients with atopic dermatitis and 18% in patients without atopic dermatitis, in 2020. In addition, as per the same source, the pooled prevalence of rhinitis and asthma was 14.2% in patients with atopic dermatitis.

In addition, food allergy is a growing health concern, with increasing prevalence in both developed and developing countries. For instance, according to the 2022 statistics published by the Food Allergy Research and Education, about 2.8 million Americans are expected to have egg allergy, 2.5 million wheat allergy, in 2020, Thus, the rising burden of various allergic diseases among the population increases the demand for early detection and diagnosis of the allergen which is expected to increase the demand for effective diagnostic tests or systems, which in turn is anticipated to propel the market growth.

Furthermore, the increasing focus of the companies on research and development activities to develop novel diagnostic products, tests, or kits to cater to high unmet medical needs is highly impacting the market’s growth. For instance, in November 2020, Omega Diagnostics received approval from the China National Medical Products Administration (NMPA) for Omega's food detective test in China. Also, in August 2020, HYCOR Biomedical and Changsha Haike Biotechnology Co., Ltd., registered its ALLEOS 2000 allergy testing system in China Hunan Medical Products Administration (HMPA).

However, the lack of awareness about allergic diseases and the affordability of allergy diagnostics are likely to impede the market growth over the forecast period.

Allergy Diagnostics Market Trends

Inhaled Allergens Segment Expects to Register a High CAGR in the Allergy Diagnostics Market Over the Forecast Period

Inhaled allergies are the most common type of allergy. Several airborne pollutants, both indoors and outside, might result in inhalant allergies. Inhalant allergies of the seasonal variety, usually known as hay fever, are among the most prevalent. Air pollution can also trigger symptoms. Common outdoor allergens irritants include pollen, mold spores, fungi, dust, and others, and indoor allergens include animal dander, dust mites, fragrances, etc.

The Inhaled Allergens Segment is expected to witness significant growth in the allergy diagnostics market over the forecast period owing to the factors such as increasing environmental pollution, increased incidences of respiratory allergies and asthma across the globe, and high demand for allergy testing. For instance, according to an article published by the Multidisciplinary Digital Publishing Institute, in October 2021, titled ‘Prevalence and Risk Factors of Self-Reported Perfume Sensitivity in Saudi Arabia’, a cross-sectional study of adults (n=1078) in Saudi Arabia was conducted, in October 2020, in which 14.6% of individuals reported to have perfume sensitivity reactions and 17.8% of individuals experienced moderate to severe reactions to perfumes. In addition, as per the same source, it has been observed that the individuals were having the highest sensitivity (47.8%) to Parfum, a type of Perfume. This is expected to increase the demand for diagnostic testing to detect the allergy-causing substance in perfumes, thereby fueling the market growth.

Furthermore, due to the rapid rise in urbanization, industrialization, and the resultant lifestyle changes, a steep rise in air pollutants has been observed in the countries leading to an increase in the number of allergies caused by air pollution such as asthma, allergic rhinitis, and others. For instance, according to the World Air Quality Report, published by IQAir, in March 2022, India is the fifth most polluted country among 117 countries, regions, and territories around the world. The annual average PM2.5 levels reached 58.1 micrograms per cubic meter (µg/m3) in 2021, in India. Thus, with the rising airborne allergens, the need for early diagnosis and treatment is expected to increase which in turn is expected to increase the demand for diagnostic tests and systems to identify the pollutant causing allergies, thereby propelling the market growth.

Therefore, the due to aforementioned factors the studied market is expected to increase over the forecast period.

North America Dominates the Market and Expects to do Same Over the Forecast Period

North America is expected to dominate the allergy diagnostics market owing to the factors such as the increasing incidence and prevalence of allergic diseases and related conditions, environmental pollution, rising healthcare spending, and growing company activities.

The COVID-19 outbreak in the North American region had a significant impact on allergist practices, including the diagnosis of allergy diseases and adaptation to state-wide restrictions on non-essential medical visits and testing as well as the reduction of the risk of disease transmission to healthcare professionals, employees, and patients. Additionally, the Centers for Disease Control and Prevention (CDC) has issued several guidelines for medical professionals, including the use of suitable personal protective equipment (PPE) and the evaluation and testing of patients suspected of having the COVID-19 virus. It has become more important than ever to recognize the differences between allergies, infection with COVID-19, and other common upper respiratory diseases.

In addition, the rising healthcare spending in the region is expected to increase the company’s activities for developing advanced treatments, thereby propelling market growth. For instance, according to the Organization for Economic Co-operation and Development (OECD), in June 2022, United States healthcare spending, in 2021 was 17.8% of the total GDP of the country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled “CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures”, it has been observed that the annual growth in national health spending is expected to average 5.1% over 2021-2030. In addition, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030. Thus, the increasing healthcare spending is expected to increase the company activities in developing technologically advanced diagnostic systems and tests to easily and quickly identify the type of allergens, which in turn is anticipated to fuel the market growth in the region over the forecast period.

Furthermore, the growing company activities and increasing product approvals in the region are also expected to propel the market growth over the forecast period. For instance, In August 2022, the United States Food and Drug Administration approved Thermo Fisher’s ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame allergies for in vitro diagnostic use. This test helps specialists and other healthcare providers identify wheat and sesame allergies in patients at risk for severe allergic reactions. Also, in September 2021, the United States Food and Drug Administration approved the ImmunoCAP Specific IgE alpha-Gal Allergen Component test for in vitro diagnostic use. The tests help in diagnosing a patient's sensitization to the alpha-Gal carbohydrate found in mammalian (red) meat and assess his or her risk for an anaphylactic reaction.

Therefore, the due to aforementioned factors the studied market is expected to increase over the forecast period.

Allergy Diagnostics Industry Overview

The allergy diagnostics market is fragmented, and competitive, and consists of several market players. The presence of major market players, such as BioMerieux SA, Thermo Fischer Scientific Inc, Omega Diagnostics, Siemens Healthineers AG, Minaris Medical America, and Danaher Corporation, intensifies the market competition. The increasing innovation and investment by various public and private organizations are expected to intensify the industry rivalry worldwide.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support